Characteristics of infants exposed to maternal tuberculosis and chemoprophylaxis using 3 months of isoniazid and rifampicin

References

• Goletti D, Weissman D, Jackson RW, Graham NM, Vlahov D, Klein RS, et al. Effect of Mycobacterium on HIV replication. Role of immune activation. J Immunol. 1996;157:1271–8.
   Google Scholar
• World Health Organization. Disease burden and 2015 targets assessments. In: WHO global tuberculosis report, 20th edn. Available from: www.who.int/tb/publications/global_report/en/
   Google Scholar
• Ormerod P. Tuberculosis in pregnancy and the puerperium. Thorax. 2001;56:494–9.
   PubMed Web of Science ®Google Scholar
• Connolly M, Nunn P. Women and tuberculosis.World. Health Stat Q. 1996;49:115–19.
   PubMedGoogle Scholar
• Holmes CB, Hausler H, Nunn P. A review of sex differences in the epidemiology of tuberculosis. Int J Tuberc Lung Dis. 1998;2:96–104.
   PubMed Web of Science ®Google Scholar
• UNAIDS. UNICEF data. Monitoring the Situation of Children and Women. Aids and HIV Estimates, 2015. Available from: http://data.unicef.org/hiv_aids/global.trends.html
   Google Scholar
• Pillay T, Khan M, Moodley J, Adhikari M, Padayatchi N, Naicker V, et al. The increasing burden of tuberculosis in pregnant women, newborns and infants under 6 months of age in Durban. KwaZulu-Natal. S Afr Med J. 2001;91:983–7.
   PubMed Web of Science ®Google Scholar
• Murray CJL, Lopez LA. Mortality by cause for eight regions of the world: Global Burden of Disease study. Lancet Infect Dis. 1997;349:1269–76.
   Google Scholar
• Pillay T, Khan M, Moodley J, Adhikari M, Coovadia H. Perinatal tuberculosis and HIV-1: considerations for resource-limited settings. Lancet Infect Dis. 2004;4:155–65.
   PubMed Web of Science ®Google Scholar
• Khan M, Pillay T, Moodley JM, Connolly CA. Maternal mortality associated with tuberculosis-HIV-1 co-infection in Durban. South Africa. AIDS. 2001;15:1857–63.
   Google Scholar
• Ahmed Y, Mwaba P, Chintu C, Grange JM, Ustianowski A, Zumla A. A study of maternal mortality at the University Teaching Hospital, Lusaka, Zambia: the emergence of tuberculosis as a major non-obstetric cause of maternal death. Int J Tuberc Lung Dis. 1999;3:675–80.
   PubMed Web of Science ®Google Scholar
• Snider DE Jr, Bloch A. Congenital tuberculosis. Tubercle. 1984;65:81–2.
   PubMedGoogle Scholar
• Pillay T, Sturm AW, Khan M, Adhikari M, Moodley J, Connolly C, et al. Vertical transmission of Mycobacterium tuberculosis in KwaZulu Natal: impactof HIV-1 co-infection. Int J Tuberc Lung Dis. 2004;8:59–69.
   PubMed Web of Science ®Google Scholar
• Cantwell FM, Shehab ZM, Costello AM, Sands L, Green F, Ewing EP Jr, et al. Brief report: congenital tuberculosis. N Engl J Med. 1994;330:1051–4.
   PubMed Web of Science ®Google Scholar
• Abhugali N, Van der Kuyp F, Annable W, Kumar ML. Congenital tuberculosis. Pediatr Infect Dis J. 1994;13:738–41.
   PubMed Web of Science ®Google Scholar
• Adhikari M, Pillay T, Pillay DG. Tuberculosis in the newborn: an emerging disease. Pediatr Infect Dis J. 1997;16:1108–12.
   PubMed Web of Science ®Google Scholar
• Pillay T, Adhikari M, Mokili J, Moodley D, Connolly C, Doorsamy T, et al. Severe, rapidly progressive human immunodeficiency virus type 1 disease in newborns with infections. Pediatr Infect Dis J. 2001;20:404–10.
   PubMed Web of Science ®Google Scholar
• Jana N, Vasishta K, Saha SC, Gosh K. Obstetrical outcomes among women with extrapulmonary tuberculosis. N Engl J Med. 1999;341:645–9.
   PubMed Web of Science ®Google Scholar
• National Department of Health, South Africa. National Tuberculosis Management Guidelines, 2008. Available from: www.who.int/hiv/pub/guidelines/southafrica_tb.pdf
   Google Scholar
• van Zyl S, Marais BJ, Hesseling AC, Gie RP, Beyers N, Schaaf HS. Adherence to anti-tuberculosis chemoprophylaxis and treatment in children. Int J Tuberc Lung Dis. 2006;10:13–18.
   PubMed Web of Science ®Google Scholar
• Marais BJ, van Zyl S, Schaaf HS, van Aardt M, Gie RP, Beyers N. Adherence to isoniazid preventive chemotherapy: a prospective community based study. Arch Dis Child. 2006;91:762–5.
   PubMed Web of Science ®Google Scholar
• National Department of Health, South Africa. Tuberculosis; congenital. In: Standard Treatment Guidelines and Essential Drug List for South Africa: Hospital Level Paediatrics, 2nd edn, 2006; ch 15, p 266. Available from: www.doh.gov.za
   Google Scholar
• Velaphi SC, Saloojee H, eds. Tuberculosis: Evaluation and Management of Infants Born to Mothers with Tuberculosis. Chris Hani Baragwanath Academic Hospital, Neonatal Unit Protocols, 3rd edn, 2010; pp. 113–14.
   Google Scholar
• Bekker A, Du Preez K, Schaaf HS, Cotton MF, Hesseling AC. High tuberculosis exposure among neonates in a high tuberculosis and human immunodeficiency virus burden setting. Int J Tuberc Lung Dis. 2012;16:1040–6.
   PubMed Web of Science ®Google Scholar
• Kali PB, Gray G, Violari A, Chaisson RE, McIntyre JA, Martinson NA. Combining PMTCT with active case finding for tuberculosis. J Acquir Immune Defic Syndr. 2006;42:379–81.
   PubMed Web of Science ®Google Scholar
• Juneja Y, Goel U, Sood M. Changing trends in maternal mortality over a decade. Int J Gynaecol Obstet. 1994;46:265–9.
   PubMed Web of Science ®Google Scholar
• Figueroa Damian R, Arredondo Garcia JL. Tuberculosis in the pregnant woman. Ginecol Obstet Mex.1992;60:209–16.
   PubMedGoogle Scholar
• Figueroa-Damian R, Arredondo-Garcia JL. Neonatal outcome of children born to women with tuberculosis. Arch Med Res. 2001;32:66–9.
   PubMed Web of Science ®Google Scholar
• Jana N, Vasishta K, Jindal SK, Khunnu B, Ghosh K. Perinatal outcome in pregnancies complicated by pulmonary tuberculosis. Int J Gynaecol Obstet. 1994;44:119–24.
   PubMed Web of Science ®Google Scholar
• Brocklehurst P, French R. The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis. Br J Obstet Gyaenacol. 1998;105:836–48.
   PubMedGoogle Scholar
• Dreyfuss ML, Msamanga GI, Spiegelman D, Hunter DJ, Urassa EJ, Hertzmark E, et al. Determinants of low birth weight among HIV-infected pregnant women in Tanzania. Am J Clin Nutr. 2001;74:814–26.
   PubMed Web of Science ®Google Scholar
• Mnyani CN, McIntyre JA. Tuberculosis in pregnancy. Br J Obstet Gynaecol. 2011;118:226–31.
   Google Scholar
• International Union Against Tuberculosis Committee on Prophylaxis. Efficacy of various duration of isoniazid preventive therapy for tuberculosis: five years of follow-up in the IUAT trial. Bull WHO. 1982;60:555–64.
   PubMed Web of Science ®Google Scholar
• Ormerod LP. Reduced incidence of tuberculosis by prophylactic chemotherapy in subjects showing strong reactions to tuberculin testing. Arch Dis Child. 1987;62:1005–8.
   PubMed Web of Science ®Google Scholar
• Ormerod LP. Rifampicin and isoniazid prophylactic chemotherapy for tuberculosis. Arch Dis Child. 1988;78:169–71.
   Google Scholar
• Spyridis N, Panayotis G, Spyridis NP, Gelesme A, Sypsa V, Valianatou M, et al. The effectiveness of a 9-month regimen of isoniazid alone versus 3- and 4-month regimens of isoniazid plus rifampin for treatment of latent tuberculosis infection in children: results of an 11-year randomized study. Clin Infect Dis. 2007;45:715–22.
   PubMed Web of Science ®Google Scholar
• Hong Kong Chest Service/Tuberculosis Research Centre MBMRC. A double-blind placebo-controlled clinical trial of three antituberculosis chemoprophylaxis regimens in patients with silicosis in Hong Kong. Am Rev Respir Dis. 1992;145:36–41.
   PubMed Web of Science ®Google Scholar
• Ormerod LP. Chemotherapy and management of tuberculosis in the United Kingdom: recommendations. Thorax. 1998;53:536–48.
   PubMed Web of Science ®Google Scholar
• Sherman GG, Lilian RR, Bhardwaj S, Candy S, Barron P. Laboratory information system data demonstrate successful implementation of the prevention of mother-to-child transmission programme in South Africa. S Afr Med J. 2014;104:235–8.
   PubMed Web of Science ®Google Scholar